• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Appl Microbiol Biotechnol . Comparison of analytical sensitivity and efficiency for SARS-CoV-2 primer sets by TaqMan-based and SYBR Green-based RT-q

tetano

Editor, Senior Moderator
Appl Microbiol Biotechnol


. 2022 Feb 26.
doi: 10.1007/s00253-022-11822-4. Online ahead of print.
Comparison of analytical sensitivity and efficiency for SARS-CoV-2 primer sets by TaqMan-based and SYBR Green-based RT-qPCR


Yile Tao[SUP] 1 2 [/SUP], Yang Yue[SUP] 1 2 [/SUP], Guangyu Qiu[SUP] 1 2 [/SUP], Zheng Ji[SUP] 3 [/SUP], Martin Spillman[SUP] 1 2 [/SUP], Zhibo Gai[SUP] 4 [/SUP], Qingfa Chen[SUP] 5 [/SUP], Michel Bielecki[SUP] 6 [/SUP], Michael Huber[SUP] 7 [/SUP], Alexandra Trkola[SUP] 7 [/SUP], Qiyuan Wang[SUP] 8 9 [/SUP], Junji Cao[SUP] 8 9 [/SUP], Jing Wang[SUP] 10 11 [/SUP]



Affiliations

Abstract

The pandemic of coronavirus disease 2019 (COVID-19) continues to threaten public health. For developing countries where vaccines are still in shortage, cheaper alternative molecular methods for SARS-CoV-2 identification can be crucial to prevent the next wave. Therefore, 14 primer sets recommended by the World Health Organization (WHO) was evaluated on testing both clinical patient and environmental samples with the gold standard diagnosis method, TaqMan-based RT-qPCR, and a cheaper alternative method, SYBR Green-based RT-qPCR. Using suitable primer sets, such as ORF1ab, 2019_nCoV_N1 and 2019_nCoV_N3, the performance of the SYBR Green approach was comparable or better than the TaqMan approach, even when considering the newly dominating or emerging variants, including Delta, Eta, Kappa, Lambda, Mu, and Omicron. ORF1ab and 2019_nCoV_N3 were the best combination for sensitive and reliable SARS-CoV-2 molecular diagnostics due to their high sensitivity, specificity, and broad accessibility. KEY POINTS: • With suitable primer sets, the SYBR Green method performs better than the TaqMan one. • With suitable primer sets, both methods should still detect the new variants well. • ORF1ab and 2019_nCoV_N3 were the best combination for SARS-CoV-2 detection.

Keywords: COVID-19; RT-qPCR; SARS-CoV-2; SYBR Green; TaqMan probe.
 
Back
Top Bottom